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Introduction
Lupus erythematosus (LE) is an inflammatory and autoimmune connective-tissue disease that predominately affects the skin. Skin manifestations of LE are divided into LE-specific and LE-nonspecific skin lesions. LE-specific lesions include chronic, subacute and acute types. Discoid lupus erythematosus (DLE) is the most common form of chronic cutaneous lupus erythematosus (LE) [1] . DLE occurs more frequently in women aged in their 40s and 50s [2] . DLE may be present alone or occur in 20% of patients with systemic lupus erythematosus (SLE). DLE generally attacks the head and neck, particularly the scalp and ears. When DLE appears on the trunk, it is associated with an increased risk of progression to SLE [3] . LE is characterized by autoantibodies and immune complexes that are a consequence of loss of immune tolerance. However, the pathogenesis of DLE remains mostly unknown. T helper-1 (Th1) dominated inflammation is thought to play a role in the etiology of DLE [4] .
Platelets (PLT) play a role in inflammatory reactions and immune response. Mean platelet volume (MPV) has been identified as a platelet activation marker that significantly affects inflammatory reactions [5] . Platelet distribution width (PDW), that shows the heterogeneity in PLT morphology, is clinically related to PLT activation [6] . Plateletcrit (PCT) is a novel biomarker in inflammatory and vascular diseases such as Crohn's disease, coronary artery disease, deep vein thrombosis and sepsis. The resulting PCT provides more comprehensive information about the total platelet mass than other platelet parameters and is more sensitive [7] . Among other parameters, the ratio of neutrophils to lymphocytes (NLR) and the ratio of platelets to lymphocytes (PLR) are simple markers of systemic inflammatory response. These parameters are commonly evaluated during routine blood tests [8] . Recently, they have been studied, individually or together, in relation to various dermatologic diseases such as psoriasis, rheumatologic diseases of dermatology, cutaneous vasculitis, atopic eczema, pityriasis rosea, Behçet's disease, recurrent aphthous stomatitis and pemphigus vulgaris [5, [9] [10] [11] . There are no studies in the literature that investigate the relationship between DLE and these inflammatory markers, and to the best of our knowledge, this is the first study to examine the association between these markers and DLE.
This study aims to evaluate the relationship between MPV, PDW, PCT, NLR and PLR levels in patients with DLE compared to healthy controls and to ask: 'Can these markers be a specific indicator in disease?'.
Materials and methods
This study was approved by the Institutional Review Board on 17.04.2019 and numbered: 2019/74. This was a retrospective, case-control study conducted between January 2013 and March 2019. The study group consisted of patients with DLE of the face, scalp, neck and body and included healthy controls who had never experienced DLE. The demographic characteristics and laboratory information for both the sample and the controls were recovered from the health center's database. The data consisted of age, sex, laboratory markers as white blood cell count (WBC; K/uL), platelet count (PLT, K/uL), PCT, MPV (K/uL), neutrophil count (NE; K/uL), lymphocyte count (LY; K/uL), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR).
The diagnosis of DLE in the patient group involved a combination of physical examination, histology and antibody serology. Patients with dermatological diseases other than DLE or who had an active infection, malnutrition, anemia, thrombocytopenia, immunodeficiency, chronic inflammatory skin disease, rheumatologic, hematologic, cardiac diseases, systemic lupus erythematosus or who used medication were excluded. The healthy control group comprised subjects chosen from the database who had no DLE or any other active infection, no systemic or dermatological-inflammatory disease and no history of medication use.
Statistical analysis
The data obtained for the study were analyzed using SPSS (Statistical Package for Social Sciences) for Windows 22.0. Number, percentage, mean and standard deviation were used as descriptive statistical methods for the evaluation of the data. The power of the test was calculated with G*Power 3.1 program. A sample size of 70 people, 35 in each group, was needed for 80% power and 0.05 type-1 error at 95% confidence interval (df=39; t=1.668). The t-test was used to compare the quantitative continuous data between the two independent groups. The relationship between variables was tested by chisquare analysis. The findings were evaluated at a 95% confidence interval and at a 5% significance level.
Results
Sixty patients with DLE and 65 healthy controls were evaluated in this study. The median age of the patient and control groups were 47.30 (15.14) years and 38.08 (13.33) years, respectively. The mean age of the patient group (47.3) was higher than the mean age of the control group (38.1) (t (123) =3.620; P<0.001). Twenty (33.3%) patients were male and 40 (66.7%) were female; 33 (50.8%) control group participants were male and 32 (49.2%) were female. Women were significantly more common in the DLE group (x 2 =3.884; P=0.036). The proportion of men in the control group was higher than in the patient group (Table 1) . We did not find any significant differences between the groups according to the WBC, MPV, PLT, NLR, PLR, PDW, PCT values (P=0.481, P=0.160, P=0.365, P=0.898, P=0.887, P=0.988 and P=0.851, respectively). The laboratory findings are summarized in Table  2 . [1] . PLT activation has been observed in patients with SLE; this PLT activation can make up the decrease in the PLT count consumed in SLE [12, 13] .
Complete blood count parameters can be calculated easily in routine and low-cost laboratory tests and provide very important markers of systemic inflammation [14] . In particular, PDW and MPV levels have been examined in recent studies. They have become popular and vital markers of PLT activation. In a study, Kim et al. [15] found higher PDW and MPV values in patients with psoriasis, a chronic inflammatory skin disease like DLE. In another study with lichen planus, Özlü et al. [16] found higher PDW levels and lower MPV levels in the patient group when compared to a control group. Studies with SLE showed lower MPV values and higher PDW values in patients and a positive relationship between PDW and disease activity [17, 18] . In these studies, the decreased MPV values were explained by the consumption of large activated PLTs in extravascular sites of inflammation [19] . In our study, we did not find a significant difference between PDW and MPV levels in DLE patients and the healthy control group. This can be explained by the low rate of systemic association in patients with DLE and some differences in the pathogenesis, especially cutaneous inflammatory infiltrates that are dominated by Th1, but not Th17 in DLE cells in contrast to systemic lupus erythematosus.
Few dermatological studies have examined NLR and PLR in patients with psoriasis. Two of these studies reported a significant increase in NLR among patients relative to the control subjects [5, 20] . Other studies have investigated the use of NLR and PLR with diabetes mellitus, acute coronary syndrome, ulcerative colitis, end-stage renal disease, tuberculosis, rheumatoid arthritis, cirrhosis, and familial Mediterranean fever [21, 22] . There was no significance in PLR and NLR in our study.
In addition to the other studies mentioned, PCT has been recognized as a systemic inflammatory response marker. There has been no study that considers the relationship between PCT and dermatological diseases. In one study of an inflammatory disease, PCT was significantly elevated in patients with Crohn's disease compared with healthy controls [7] .
There were some limitations to our study. First, this was a retrospective study and some of the patients' characteristics, such as their smoking history and dietary habits, were inadequate for evaluating their co-effects on the PLT indices and other factors. Second, as the study was retrospective, we could not investigate the relationship with disease severity. Third, the numbers of patients and controls were relatively small. Multicenter, prospective studies with larger sample sizes should be conducted in the future.
Conclusion
Our study provides the first report that the PLT and PLT parameters did not show a significant difference in insulating DLE patients. Further prospective works are needed to better understand the relevance of these findings.
